.svg){kind=small}
Mar-2024
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
In the competitive cannabis landscape of Colorado, Aliviar has shown noteworthy performance in the Tincture & Sublingual category, maintaining a strong presence within the top 5 rankings from December 2023 through March 2024. The brand climbed from a rank of 4 in December to a peak of 3 in January, before slightly dipping to rank 5 in the subsequent months. This movement indicates a robust demand for Aliviar's offerings in this category, underscored by a significant sales jump from $24,494 in December to $32,197 in January. Although there was a slight decrease in February, sales rebounded in March to $32,649, highlighting a consistent consumer interest and the brand's resilience in maintaining its market position amidst fierce competition.
On the other hand, Aliviar's performance in the Topical category tells a different story of fluctuating fortunes. While the brand managed to stay within the top 12 rankings from December 2023 to March 2024, it experienced a slight rank improvement from 11 in December to 10 in January and March, with a dip to 12 in February. This inconsistency in rankings reflects the challenges faced by Aliviar in securing a stronger foothold in the Topical market segment. Despite these fluctuations, the brand's ability to remain in the top 12 suggests a steady, if not dominant, consumer base. However, the sales dip in February to $7,472, before partially recovering in March to $8,626, indicates potential volatility in consumer preferences or competitive dynamics within this category.
Competitive Landscape
In the competitive landscape of the Tincture & Sublingual category in Colorado, Aliviar has demonstrated a fluctuating performance in terms of rank and sales over the recent months. Initially ranked 4th in December 2023, Aliviar climbed to 3rd in January 2024, showcasing a significant increase in sales. However, it experienced a slight dip to 5th place by March 2024, despite an increase in sales figures. This indicates a highly competitive market, where even with sales growth, rank can be affected by the performance of competitors. Notably, My Brother's Flower and Stratos have been key competitors, with My Brother's Flower initially leading in December but being overtaken by Stratos in terms of rank by March 2024. Both brands showed consistent sales growth, highlighting the dynamic nature of consumer preferences and the importance of staying competitive in product offerings and marketing strategies. Care Division and Mary's Medicinals also remain significant players, maintaining steady ranks and showing sales growth, further emphasizing the competitive environment Aliviar operates in.
Notable Products
In Mar-2024, Aliviar's top-performing product was the CBD/THC 20:1 Calm Tincture (1400mg CBD, 70mg THC) from the Tincture & Sublingual category, maintaining its number one rank since Dec-2023 with sales reaching 1023 units. Following closely, the CBD/THC/CBN 5:1:1 Sleep Tincture (250mg CBD, 50mg THC, 50mg CBN, 10ml) held its second position consistently through the months, showing a notable sales increase to 301 units in March. The third spot was secured by the CBD/THC 2:1 Scented Cream (420mg CBD, 210mg THC, 2oz) in the Topical category, which also retained its ranking from the previous months, marking a steady presence in the top three. The CBD/THC 2:1 Sport Cream (420mg CBD, 210mg THC,2oz) improved its position to fourth in March, up from fifth, indicating a growing interest in Aliviar's topical solutions. Interestingly, the rankings of these top products have shown remarkable consistency over the past four months, highlighting strong customer loyalty and product satisfaction within Aliviar's offerings.
Top Selling Cannabis Brands
